ADMA Biologics, Inc. (ADMA): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

244.90M
Year ended 2025-12-31
+7.4%
3-year compound annual growth
+23.2%
5-year compound annual growth
2020-12-31: 86.15M2021-12-31: 139.58M2022-12-31: 197.87M2023-12-31: 223.98M2024-12-31: 243.34M2025-12-31: 244.90M244.90M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31244.90M+0.6%2026-02-25, From 2025-01-01
2024-12-31243.34M+8.6%2026-02-25, From 2024-01-01
2023-12-31223.98M+13.2%2026-02-25, From 2023-01-01
2022-12-31197.87M+41.8%2025-03-18, From 2022-01-01
2021-12-31139.58M+62.0%2024-02-28, From 2021-01-01
2020-12-3186.15Mn/a2022-03-24, From 2020-01-01